SCHEMBL26124183

SCHEMBL26124183

O=C(O)[C@H]1CCCN1C(=O)Cc1ccc(F)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 9/20 0.59
KMT2A Q03164 2/20 0.49
THRB P10828 1/20 0.49
ALOX12 P18054 1/20 0.49
DPP4 P27487 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
ACE P12821 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26124386 1.00 P2RX7 (0.59) P2RX7KMT2ATHRBALOX12DPP4
SCHEMBL26123844 0.88 P2RX7 (0.63) P2RX7KMT2ADPP4MEN1CYP2D6
SCHEMBL26123848 0.88 P2RX7 (0.63) P2RX7KMT2ADPP4MEN1CYP2D6
SCHEMBL26124728 0.88 P2RX7 (0.63) P2RX7KMT2ADPP4MEN1CYP2D6
SCHEMBL9538607 0.88 ALDH1A1 (0.52) P2RX7KMT2AALDH1A1ACE
SCHEMBL30546740 0.86 P2RX7 (0.61) P2RX7DPP4ALDH1A1CYP2D6CYP2C19
SCHEMBL30546762 0.86 P2RX7 (0.61) P2RX7DPP4ALDH1A1CYP2D6CYP2C19
SCHEMBL30546732 0.81 SMN1; SMN2 (0.65) P2RX7KMT2AMEN1ALDH1A1HPGD
SCHEMBL26121213 0.81 SMN1; SMN2 (0.65) P2RX7KMT2AMEN1ALDH1A1HPGD
SCHEMBL26121211 0.81 SMN1; SMN2 (0.65) P2RX7KMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188032-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USES THEREOF BNH RESEARCH CO., LTD. (KR) 2025-06-12 US disclosed
EP-4501910-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USES THEREOF BNH Research Co., Ltd. (KR) 2025-02-05 EP disclosed
CN-119255981-A Nitrogen-containing heterocyclic compound and use thereof BNH研究有限责任公司 2025-01-03 CN disclosed
WO-2023191468-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USES THEREOF 주식회사 비엔에이치리서치 2023-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188032-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USES THEREOF NLN, GRIN1, GRIN2A P2RX7 424/4885KMT2A 687/4885THRB 4086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.